MODEYSO

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Aug 06, 2025

   11 mo ago

2. Today

3. Exclusivity ends · NCE

   New chemical entity exclusivity (5 years)

   Aug 06, 2030

   in 4 yr 2 mo

4. Patent 9629842 expires

   Listed method-of-use patent (U-4254) expiration.

   Apr 30, 2032

   in 5 yr 11 mo

5. Patent RE46290 expires

   Listed method-of-use patent (U-4254) expiration.

   Apr 30, 2032

   in 5 yr 11 mo

6. Exclusivity ends · ODE-547

   Orphan-drug exclusivity (7 years)

   Aug 06, 2032

   in 6 yr 3 mo

7. Patent 9265765 expires

   Listed drug product patent expiration.

   Jul 26, 2034

   in 8 yr 3 mo

8. Patent 11976068 expires

   Listed drug product patent expiration.

   Mar 01, 2036

   in 9 yr 10 mo

9. Patent 10172862 expires

   Listed method-of-use patent (U-4254) expiration.

   Jan 30, 2037

   in 10 yr 9 mo

10. Patent 10369154 expires

    Listed method-of-use patent (U-4254) expiration.

    Jan 30, 2037

    in 10 yr 9 mo

11. Patent 12102639 expires

    Listed method-of-use patent (U-4254) expiration.

    Jan 30, 2037

    in 10 yr 9 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (2)

• NCENew chemical entity exclusivity (5 years)

  Aug 06, 2030

  in 4 yr 2 mo

• ODE-547Orphan-drug exclusivity (7 years)

  Aug 06, 2032

  in 6 yr 3 mo

Listed patents (7)